AN2 Therapeutics, Inc.
USD5.03
-0.17 (-3.27%)
CEO
Eric E. Easom
IPO Date
2022-03-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.23
Prev. Close
$5.20
Day Low
$4.71
Day High
$5.23
52W Low
$1.00
52W High
$6.91
Market Cap
$0.14B
Volume
0.31M
| 3,775 |
| $0.00 |
| 10 Apr 2026 | Marks Gilbert Lynn | director | A-Award | Acquired | 3,775 | $0.00 |
| 10 Apr 2026 | Martin Patricia A. | director | A-Award | Acquired | 1,192 | $0.00 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | A-Award | Acquired | 73,665 | $3.91 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | D-Return | Disposed | 73,665 | $6.60 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | A-Award | Acquired | 66,000 | $3.91 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | D-Return | Disposed | 66,000 | $17.28 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | A-Award | Acquired | 82,300 | $3.91 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | D-Return | Disposed | 82,300 | $14.29 |